Position
Chief Business Officer
Company
Kenai Therapeutics
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Kenai Therapeutics has announced the appointment of Blake Arnold as Chief Business Officer. In this role, he will lead the company's business development and corporate development initiatives.
Quick answer
Kenai Therapeutics Appoints Blake Arnold as Chief Business Officer (February 24, 2026). Kenai Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Business Officer at Kenai Therapeutics?
- Kenai Therapeutics named Blake Arnold Chief Business Officer, announced February 24, 2026.
- What did Kenai Therapeutics announce on February 24, 2026?
- Kenai Therapeutics has announced the appointment of Blake Arnold as Chief Business Officer. In this role, he will lead the company's business development and corporate development initiatives.
- What does Kenai Therapeutics do?
- Kenai Therapeutics is a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders.
- Where is Kenai Therapeutics based?
- Kenai Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- XenoSTART (February 24, 2026), Foghorn Therapeutics (February 23, 2026), Insitro (February 26, 2026) and Pulse Biosciences, Inc. (February 27, 2026) also announced leadership changes within 45 days of Kenai Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- XenoSTART Appoints Frank Smith as President (February 24, 2026)
- Foghorn Therapeutics Appoints Ryan Maynard as Chief Financial Officer (February 23, 2026)
- insitro Appoints Joe Hand as Chief People Officer (February 26, 2026)
- Pulse Biosciences Announces Resignation of Chief Commercial Officer (February 27, 2026)
- Argo Biopharma Appoints Gena Wang as Chief Financial Officer and Chief Strategy Officer (March 2, 2026)
- EyePoint Appoints Michael Campbell as Chief Commercial Officer (February 18, 2026)
Who to call at Kenai Therapeutics, and when
A new leader at Kenai Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kenai Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kenai Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kenai Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kenai Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kenai Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.